About the Company
Science
Medications
Careers
Press Center
Pharmacovigilance
+7 (495) 684-43-33
РУ EN
+7 (495) 684-43-33
  • About the Company
  • Science
  • Medications
  • Careers
  • Press Center
  • Pharmacovigilance

    • Company News

    Материа Медика
    15.03.2010

    Аnaferon for children is registered in vitally important medicines list

    Roszdravnadzor (HealthCare Ministry) has registered the price for Anaferon for children in the list of vitally important medicines...
    Материа Медика
    15.03.2010

    USA has issued patent for Impaza

    USA patent department has issued patent for unique composition which is the base for Impaza...
    Материа Медика
    25.12.2009

    Merry Christmas and happy New Year 2010!

    From all of us at Materia Medica, best wishes of this joyous season! May this New Year bring many opportunities, happiness and fulfillment to you, your family and business, turning all efforts into great achievements.
    Материа Медика
    18.12.2009

    Anaferon` Patent registered in the U.S.

    U.S. Patent Office granted a patent for a unique composition, on the basis of which a popular Russian antiviral drug Anaferon is produced. So far, patents have been obtained only in Russia and CIS countries.
    Материа Медика
    20.08.2009

    The company "Materia Medica" got the GMP certificate

    All products manufactured by the company complies with GMP and Russian Legislation.
    Материа Медика
    05.08.2009

    New Representative Office of Materia Medica Holding Opened in Alma-Ata

    We announce the opening of Materia Medica Representative Office in Alma-Ata to support the business development in Central Asia.
    Материа Медика
    20.09.2007

    Manufacture Upgraded

    NPF Materia Medica Holding’s new manufacturing sites were equipped with the leading-edge manufacturing equipment from Germany and Italy.
    Company News 50 - 56 из 56
     Начало | Пред. | 4 5 6 7 8 | След. | Конец